Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation

Kazuhiko Kido; Mikiko Shimizu; Tsuyoshi Shiga; Masayuki Hashiguchi

doi:10.1016/j.amjcard.2020.09.003

Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation

Kazuhiko Kido, Mikiko Shimizu, Tsuyoshi Shiga, Masayuki Hashiguchi

School of Pharmacy

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	160-161
Number of pages	2
Journal	American Journal of Cardiology
Volume	134
DOIs	https://doi.org/10.1016/j.amjcard.2020.09.003
Publication status	Published - 2020 Nov 1

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2020.09.003

Cite this

@article{1963ec8df8d0415da6e82fbb121c7bbc,

title = "Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation",

author = "Kazuhiko Kido and Mikiko Shimizu and Tsuyoshi Shiga and Masayuki Hashiguchi",

year = "2020",

month = nov,

day = "1",

doi = "10.1016/j.amjcard.2020.09.003",

language = "English",

volume = "134",

pages = "160--161",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation

AU - Kido, Kazuhiko

AU - Shimizu, Mikiko

AU - Shiga, Tsuyoshi

AU - Hashiguchi, Masayuki

PY - 2020/11/1

Y1 - 2020/11/1

UR - http://www.scopus.com/inward/record.url?scp=85092386856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092386856&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2020.09.003

DO - 10.1016/j.amjcard.2020.09.003

M3 - Letter

C2 - 32916147

AN - SCOPUS:85092386856

SN - 0002-9149

VL - 134

SP - 160

EP - 161

JO - American Journal of Cardiology

JF - American Journal of Cardiology

ER -

Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this